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Objective: The study aimed to explore the changes in mitochondrial DNA (mtDNA) copy number,
collagen, and matrix metalloproteinase (MMPs) expression with pelvic organ prolapse (POP) in the
uterosacral ligaments of premenopausal women.
Materials and methods: A group of 56 premenopausal women, all younger than 52 years of age, were
enrolled in this study. Uterosacral ligament (UL) biopsies were obtained from uterine specimens taken
from 22 women with POP (n ¼ 22, study group) and 34 myoma patients without POP (n ¼ 34, control
group) during abdominal or vaginal hysterectomy. Quantitative real-time polymerase chain reaction (Q-
PCR) and immunohistochemistry analysis were applied in the present study.
Results: The rate of high body mass index (BMI) (> 24 kg/m2) women was signiﬁcantly higher in the POP
group (81.8% vs. 35.3%, p ¼ 0.001 *), and the BMI of the POP women was higher than that of the nonPOP
women (p ¼ 0.029 *). The mtDNA copy number (p ¼ 0.001 *), collagen III alpha 1 (COL3a1) expression
(p ¼ 0.025 *), and MMP2 expression (p ¼ 0.047 *) were signiﬁcantly higher in the POP group when
compared with the nonPOP group. The high BMI women had a higher mtDNA copy number (p ¼ 0.002 *),
COL3a1 (p ¼ 0.028 *) gene expressions compared with the standard BMI women.
Conclusion: In the premenopausal state, higher BMI may be a stronger associate factor than vaginal birth
for the development of POP. The higher mtDNA copy number, COL3a1, and MMP2 gene expressions are
highly associated with POP in the UL of premenopausal women.
Copyright © 2016, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
Pelvic organ prolapse (POP) is a global health problem, affecting
adult females of all ages. It decreases their quality of life consid-
erably [1] and it is estimated that 50% of parous women have at
least a minor degree of POP [2]. A woman's lifetime risk of under-
going pelvic reconstructive surgery is estimated to be ~ 11%,y and Reconstructive Pelvic
Department of Vascular and
umber 135, Nanxiao Street,
bstetrics & Gynecology. Published brendering this diagnosis one of the most common indications for
surgical treatment in women [1]. Furthermore, an estimated
13e30% of women who have prolapse surgery will require a
reoperation within 5 years [3]. Numerous factors, including age,
ethnicity, parity, obesity, and history of hysterectomy, have been
found to be associated with POP [4,5].
Despite the epidemiologic importance of this disorder, our
knowledge of its pathophysiology is limited and it remains unclear
how these risk factors affect the development of prolapse andwhich
pathophysiologic mechanisms are responsible for disease manifes-
tation [6]. This knowledge may lead to preventive measures that
could eliminate or delay the onset of prolapse and improve surgical
treatment [7]. The uterosacral ligaments (UL) complex in the femaley Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
Table 1
Demographic characteristics of premenopausal patients with and without pelvic
organ prolapse (POP).
Characteristic nonPOP POP pb
(n ¼ 34) (n ¼ 22)
Age (y)a 44.9 ± 4.1 45.7 ± 4.3 0.465
BMI (kg/m2)a 23.8 ± 3.3 25.7 ± 2.7 0.029*
High BMI (%, N) (35.3,12) (81.8,18) 0.001c*
Paritya 2.6 ± 1.0 3.1 ± 1.0 0.227
NSDa 2.3 ± 1.2 3.1 ± 1.0 0.064
ATS (%, N) (47, 16) (23, 5) 0.066c
*p  0.05.
ATS ¼ abdominal tubal sterilization; BMI ¼ body mass index; High
BMI¼ BMI > 24 kg/m2; N ¼ number; nonPOP ¼ nonpelvic organ prolapse;
NSD ¼ normal spontaneous delivery; POP ¼ pelvic organ prolapse.
a Values are mean (standard deviation).
b Student t test of variance.
c Chi-square test.
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and establishes the Level 1 support of the cervix and the upper
vagina [8].Studies of UL reveal that the key elements of tissue sta-
bility include the quantity, ultrastructure, and organization of
extracellular matrix (ECM) proteins, such as collagens, ﬁbronectin
and elastin, as well as enzymes such as the matrixmetallo pro-
teinases (MMPs) which participate in the degradation of collagen
and other ECM proteins [7,9]. The mitochondria supply most of the
cellular energy through respiration and oxidative phosphorylation.
The mitochondrial DNA (mtDNA) encodes 13 essential subunits of
the respiratory enzyme complexes. In our prior study, it was found
that alternations in the mtDNA may play an important role in the
molecular pathogenesis and formation of POP [10].
To date, many studies have evaluated the risk factors affecting
the development of POP but few have evaluated how these are
associatedwith the development of POP and the possiblemolecular
pathophysiology in premenopausal women.
Aging and menopause are commonly accepted as promoting
factors of POP [7]; however, many young premenopausal women
may develop advanced POP. In this study, we only focused on
premenopausal women under 52 years of age with advanced POP
and tried to seek the important correlating factors and their
possible pathophysiologic molecular process with regard to POP
development in the premenopausal state.
Studies have revealed that being overweight is associated with
the progression of POP [11] and that the prevalence of pelvic ﬂoor
disorders increaseswith higher degrees of obesity [12]. Though POP
is often a problem associated with postmenopausal women, we
hypothesize that the changes in the elements of ECM and mtDNA
copy number may be related to POP through an energy supplying
molecular process of tissue healing remodeling in premenopausal
women. In addition, we seek to establish the relationship of BMI
with POP through the changes in ECM and mtDNA copy number.
Materials and methods
This study protocol was approved by the Institutional Review
Board of Changhua Christian Hospital, and all patients provided
informed consent before participating. We included 56 Taiwanese
premenopausal female patients younger than 52 years of age with
vaginal or abdominal hysterectomy performed for uterine prolapse
or benign uterine myoma. ‘Premenopausal’ was deﬁned as < 1 year
of amenorrhea in women aged < 52 years old. Participants
receiving estrogen/progesterone therapy, who had pelvic malig-
nancies or who had undergone prior pelvic radiation, were
excluded from this study.
Patients with myoma and without uterine prolapse (Stage 0)
were approved by a urogynecologist and recruited as the control
group; patients with prolapse (stages IIeIII) were the study group.
All of the 3e5 mm thick slices of biopsies from the medial ends
of the bilateral UL tissue were obtained using a scalpel held be-
tween two clamps during abdominal or vaginal hysterectomy at the
level of the cervical insertions to the uterus. The cervical portion of
the UL tissue usually represents a reproducible, easily-accessible
structure. All of the specimens were stored in a refrigerator
at80C until DNA and RNA puriﬁcation. The entire cellular DNA of
the UL tissue was extracted using the PUREGENETM DNA puriﬁ-
cation kit (Gentra Systems, MN, US).
The total RNA of human UL tissue specimens was extracted with
the Trizol Reagent, following the manufacturer's instructions
(Invitrogen, CA, USA).
The mRNA expression of collagen I alpha 1 (COL1a1), COL3a1,
matrixmetalloproteinase 2 (MMP2), andMMP9geneswere analyzed
via quantitative real-time polymerase chain reaction (Q-PCR). The
reaction contained 10 mL 2 TaqMan Fast Universal PCR Master Mix,1 of the primer and TaqMan FAM dye-labeled MGB probe mix for
each gene, and 2 mL of 10 ngcDNA. The thermal cycler conditions
consisted of 95C for 10 minutes, followed by 40 cycles of 95C for
15 seconds and 60C for 1minute performed byanABI Real-Time PCR
7300 instrument (Applied Biosystems, USA). All of the samples were
analyzed in duplicate and calculated by the DCt method.
DCt (sample) ¼ target gene Ct  b-actin Ct (internal control)
All biopsy specimens were ﬁxed in 10% neutral-buffered
formalin for parafﬁn-embedded tissue sections using routine
methods. Sections were cut at 4 mm thickness and mounted onto
glass slides, then allowed to dry at 37C for 12 hours. Immuno-
histochemistry (IHC) was performed using the Leica BOND-Max.
IHC quantiﬁcation uses the Image J software to measure differ-
ences in staining intensity. A total 20 ng of UL DNA was used to
determine the copy numbers of mtDNA using the Applied Bio-
systems QPCR 7300 instrument (Tri-I Biotech, Taiwan). The
primers' information was as follows: for mtDNA-ND1: Forward 50-
AACA TACCCATGGCCAACCT-30; Reverse 50-AGCGAAGGGTTGTAG-
TAGCCC-30. For b-globin: Forward 50-GAAGAGCCAAGGACAGGTAC-
30; Reverse 50-CAACTTCATCCACGTTCACC-30. The Q-PCR was modi-
ﬁed, based on our previous report, and used to determine the UL of
the mtDNA copy number [10,13].
The statistical analysis was performed using the SPSS statistical
package, version 15.0 (SPSS, Chicago, IL, USA). A student t test was
applied in the continuous variable with normal distribution
(Table 1), and a ManneWhitney U-test was applied for the com-
parison of the continuous variables with nonnormal distribution
(Table 2). A Chi-square test was applied for the comparison be-
tween the categorical variables (Table 1). Successful log trans-
formations into normal distribution were noted at value of mtDNA
copy number, COL1a1, COL3a1, MMP2, and MMP9, using the
following analysis of multiple covariate ANOVA (p > 0.05, One-
sample KolmogoroveSmirnov test). A multiple covariate ANOVA
of a general lineal mode under controlling age, number of normal
deliveries, and parity were applied in the comparison between POP
patients and the normal controls (Table 2). Another multiple co-
variate ANOVA of the general lineal mode under controlling age and
parity were applied for the comparison of higher and normal BMI
(Figure 1). The statistical signiﬁcance was set at a p value < 0.05.Results
The UL of 56 women's (34 with nonprolapse, 22 with prolapse)
biopsies were obtained from uterine specimens taken from 22
Table 2
Amounts of mtDNA copy number and expression of COL1a1, COL3a1, MMP2, and
MMP9 gene in UL with nonPOP compared with POP.
nonPOP POP pc pd
(n ¼ 34) (n ¼ 22)
mtDNA (copy number/Cell)a 2429 ± 127 3259 ± 233 0.001* 0.013*
COL1a1b 0.032 ± 0.011 0.011 ± 0.002 0.064 0.837
COL3a1b 1.131 ± 0.197 2.685 ± 0.618 0.025* 0.023*
MMP2b 0.116 ± 0.018 0.258 ± 0.065 0.047* 0.056
MMP9b 0.011 ± 0.003 0.007 ± 0.003 0.335 0.844
*p  0.05.
COL1a1 ¼ collagen type I alpha 1; COL3a1 ¼ collagen type III alpha 1;
MMP2 ¼ matrix metallopeptidase 2; MMP9 ¼ matrix metallopeptidase 9;
mtDNA ¼ mitochondrial DNA; POP ¼ pelvic organ prolapse; UL ¼ uterosacral
ligament.
a mean ± standard error.
b fold difference generated by RT-QPCR.
c ManneWhitney test.
d Multiple-covariate ANOVA under controlling confounding factor of parity,
number of delivery and age by the log transformation in data of mtDNA copy
number, COL1a1, COL3a1, MMP2, and MMP9.
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myoma patients without POP (n ¼ 34, control group). The de-
mographic and clinical characteristics among prolapse and non-
prolapse patients are shown in Table 1. All patients underwent the
stages of POP according to the International Continence Society
(ICS) criteria [14].
The mean age was 44.9 ± 0.7 for the nonprolapse group, and
45.7 ± 0.9 for the prolapse group. There were no signiﬁcant dif-
ferences between the two groups in parity and number of normal
deliverywith regard to the patient demographics (Table 1, p > 0.05).
The rate of high BMI (> 24 kg/m2) women was signiﬁcantly higher
in the POP group (81.8% vs. 35.3%, p ¼ 0.001 *), and the BMI of the
POP women was higher than that of the nonPOP women
(p ¼ 0.029 *) (Table 1).
The mtDNA copy number in the UL of premenopausal patients
with POP was signiﬁcantly higher than that of the nonPOP group
(Table 2, p ¼ 0.001 *). In addition, the prolapse group had signiﬁ-
cantly higher COL3a1 and MMP2 expressions than the nonPOP
group (Table 2, p ¼ 0.025 *; p ¼ 0.047 *). Following adjustment for
the confounding factors of age, parity, and number of normal de-
liveries, the mtDNA copy number and COL1a3 still expressed sta-
tistical signiﬁcance (p < 0.05) and borderline signiﬁcance at MMP2
(p¼ 0.056) (Table 2). Therewere no signiﬁcant differences between
the COL1a1 and MMP9 gene expressions of the POP and nonPOP
groups even after controlling for the impact of age, parity, and
number of normal deliveries (Table 2). The BMI 24 women
(n ¼ 29) had a higher mtDNA copy number (p ¼ 0.002 *), and
COL3a1 (p ¼ 0.028 *) than the normal BMI women (n ¼ 27) in the
UL of 56 patients (Figure 1) when controlling for the confounding
factors of parity, number of deliveries, and age.
To compare the POP and nonPOP group patients with the
normal BMI, there were no signiﬁcant differences between the
gene expressions of the POP and nonPOP groups except that the
COL3a1 (p ¼ 0.008 *) expression was higher in the nonPOP group.
Based on the Q-PCR results, IHC staining for COL3a1 andMMP2was
performed (Figure 2). The gene expression of MMP2 and COL3a1 in
the UL was higher in the POP group than in the nonPOP group.
Discussion
POP development is multifactorial, with vaginal child birth,
advancing age, and increasing BMI as the most consistent risk
factors [7]. Aging and menopause are commonly accepted as pro-
moting factors of POP; however, many young premenopausalwomen may develop POP. In this study, we only enrolled pre-
menopausal women younger than the age of 52 and tried to
establish the important correlated factors and their possible path-
ophysiologic molecular process for POP development in the pre-
menopausal state. In this study, only premenopausal women were
enrolled, and the age factor caused no signiﬁcant difference be-
tween the POP and nonPOP groups. Vaginal childbirth was the
factor that was most frequently associated with POP and increasing
vaginal parity was the strongest risk factor for POP inwomen under
60 years old [15]. The Women's Health Initiative noted that every
additional delivery up to ﬁve births increased the risk of worsening
prolapse by 10e20% [4]. Other obstetric factors that have been
associated with the risk of POP, albeit less consistently, include a
high infant birth weight, the delivery of a macrocosmic infant, a
prolonged second stage of labor, and age younger than 25 years at
ﬁrst delivery [16]. In this study, there were no signiﬁcant differ-
ences between the two groups in terms of parity and normal
spontaneous delivery (NSD), unlike in the above prior studies,
possibly due to the small study group. It may also indicate the
relatively lower inﬂuence of the obstetric factor in the development
of POP in premenopausal state women.
Some studies have indicated that overweight or obesity is
associated with the progression of POP [12] and positively corre-
lated with the prevalence of pelvic ﬂoor disorders [11]; however,
the longitudinal effects of being overweight on prolapse develop-
ment have been less well studied. Kudish (2009) [12] reported that
the risk of prolapse progression in overweight and obese meno-
pausal women compared to participants with a healthy BMI
increased by 32% and 48% for cystocele, by 37% and 58% for rec-
tocele, and by 43% and 69% for uterine prolapse, respectively,
indicating that being overweight may be associated with the
development or progression of POP and that overweight or obesity
is a modiﬁable risk factor for POP. In this study, most POP patients
(81.8%) had a high BMI, whereas less than half (35.3%) were in the
nonPOP group. In addition, the BMI of the POP women was higher
than that of the nonPOP women (p¼ 0.029 *), so increasing BMI
seems to play a role in the development of POP in premenopausal
women. This is in accordance with previous reports that showed
that women who are overweight [BMI: 25e30 kg/m2; odds ratio
(OR): 2.51; 95% conﬁdence interval (CI): 1.18e5.35] and obese (BMI:
>30 kg/m2; OR: 2.56; 95% CI: 1.23e5.35) are at a higher risk of
developing this disorder [15]. Similarly, individuals with a BMI of >
26 kg/m2 are more likely (OR: 3.0; 95% CI: 1.6e5.7) to undergo
surgery for prolapse than are those with a lower value [16].
The conception of the pelvic ﬂoor connective tissue of POP pa-
tients is related to tissue repair [7]. The increasing injury to the
pelvic ﬂoor may be caused by persistent or chronic intraabdominal
pressure day by day due to a higher BMI or other heavy work and
exercise, which may induce the energy needed for repair or
compensation, as opposed to parity and delivery, where the trauma
is limited to the period of the delivery process, which may play a
more important role in the development of POP.
In our previous study [10], where over 73% of the participants
were postmenopausal women, the mtDNA copy number in the UL
of patients with POP was signiﬁcantly lower than that of the non-
POP group. In contrast, this present study showed that the mtDNA
copy number in the UL of premenopausal patients with POP was
signiﬁcantly higher than that of the nonPOP group (Table 2,
p ¼ 0.001 *). In addition, the high BMI group had a higher mtDNA
copy number (Figure 1, p ¼ 0.002 *) compared with the standard
BMI group in the UL of premenopausal patients. The results support
the view that the characteristics of the pelvic ﬂoor connective tis-
sue of POP patients may be related to tissue repair [7]. When the
tissue is remodeled to accommodate a progressively increasing
mechanical load such as obesity, a compensation healing process
Figure 1. A comparison of mtDNA copy number, expression of MMP2, and COL3a1 between normal (n ¼ 27) and high BMI (n ¼ 29) women in the UL of 56 patients. The value in the
bar indicates the mean ± standard error and case number. The p value was calculated by the multiple-covariate ANOVA under controlling the confounding factors of parity, number
of deliveries, and age. ANOVA ¼ analysis of variance; BMI ¼ body mass index; MMP2 ¼ matrixmetallo proteinase 2; mtDNA ¼ mitochondrial DNA; UL ¼ uterosacral ligaments.
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supplies the energy needed during the repair process in relatively
young premenopausal women. For the successful compensation of
the pelvic ﬂoor healing process in most of the premenopausal state
and the decompensation occurring in the elderly postmenopausal
state, most cases of symptomatic POP disorder may arise a long
time after vaginal childbirth. Most women who bear children do
not have symptomatic prolapse and the relative prevalence of this
disorder rises by ~ 40% with every decade of life [17,18].
For the unsuccessful compensation of the pelvic ﬂoor healing
process due to the extensive injury caused by a higher BMI, a
symptomatic prolapse may be developed early in the premeno-
pausal state. Thus, a higher BMI may be a more important associate
factor than other obstetric factors for the development of POP in thepremenopausal state. It might be prudent to counsel our patients to
avoid weight gain and other events that increase the intra-
abdominal pressure to prevent causing additional damage to the
pelvic ﬂoor associated with childbearing and prevent the devel-
opment of POP.
In 1996, Jackson [19] presented a hypothesis on pelvic ﬂoor
connective tissue that sought to explain the development of POP on
a molecular level. The association between POP and connective
tissuemetabolism is well established. However, the causality of this
association is unclear [7], although the ﬁbrillar component of the
ECM is thought to contribute the most to the biomechanical
behavior of these tissues. The quantity and quality of collagen and
elastin are regulated through a precise equilibrium between syn-
thesis, maturation, and degradation. This process results in a
Figure 2. (A) Immunohistochemical expressions of COL3a1 and MMP2 in the UL of premenopausal patients with and without POP. (B) quantitative analysis of immunostaining
using Image J software. (Student t test; *p < 0.05).The experiment was performed a minimum of three times with similar results. COL3a1 ¼ collagen type III alpha 1;
MMP2 ¼ metalloproteinase 2; POP ¼ pelvic organ prolapse; UL ¼ uterosacral ligaments.
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that abnormalities of connective tissue and connective-tissue
repair might predispose some women to POP [19,20]. Individuals
with prolapse might have altered collagen metabolism, including a
decrease in collagen I and an increase in collagen III [16].
The quantity and organization of collagen ﬁber signiﬁcantly
affects the tensile strength and subsequently the support that is
provided to the uterus and vagina. It is known that collagen I is
responsible for the mechanical strength in connective tissues
whereas collagen III appears to play a role in tissue elasticity and
extensibility. Therefore, the higher levels of collagen III in women
with POP could be responsible for the increased tissue laxity in
these patients. [21]. The higher collagen III expression might be a
typical characteristic of POP patients' connective tissue, because the
quantity of collagen III in biopsies obtained from cardinal ligaments
is directly related to the presence of prolapse [21]. In addition,collagen III is predominant in tissues that require increased ﬂexi-
bility and distension and that are subject to periodic stress [22], and
so the increased immature collagen III content may indicate tissue
repair following the overstretching of the supportive connective
tissue of the pelvic ﬂoor. Our data are in accordance with the ex-
periments of Gabriel [21] and most studies, which indicate that the
COL3a1 expression was signiﬁcantly related to the presence of POP
(Table 2, p ¼ 0.025 *). In addition, a high BMI group had a higher
COL3a1 (Figure 1, p ¼ 0.028 *) in premenopausal women. Our
ﬁndings, similar to most studies, suggest that besides the higher
COL3a1 expression possibly being a typical characteristic of POP
patients' ECM, the COL3a1 gene expressionwas signiﬁcantly higher
in the high BMI groups compared with the standard BMI group.
When comparing the POP and nonPOP group patients with normal
BMI, only a slightly higher COL3a1 expression was noted in the
nonPOP group. These ﬁndings suggest that BMI is strongly
Table 3
The summarized prior data and this study's results of the analysis of MMPs and their inhibitors in biopsy specimens from vaginal or supportive tissue in women with or
without POP.
Study Target population and sample size Tissue analyzed Analytic methods Findings: patients with POP compared to controls
Jackson 1996 [19] 8 premenopausal women with
POP and 10 controls
Vaginal epithelium Hyp assay Increase of pro MMP2, active MMP2, and MMP9
Gabriel 2006 [23] 17 women with POP and 18 controls UL IHC Increased expression of MMP2; no difference
in expression of MMP1
Liang 2010 [28] 8 premenopausal women with POP
11 postmenopausal women with POP
and 9 controls
UL and cervical tissue Multiplex-PCR Higher expression of MMP2 mRNA and lower
expression of TIMP2 mRNA
Dviri 2011 [27] 20 women with POP and 20 controls UL and vaginal
epithelial tissue
IHC Increased MMP2 and MMP9
This study 22 premenopausal women with




COL3a1 ¼ collagen type III alpha 1; Hyp ¼ Hydroxyproline; IHC ¼ Immunohistochemistry; MMPs ¼ matrix metalloproteinases; MMP1 ¼ matrix metallopeptidase 1;
MMP2 ¼ matrix metallopeptidase 2; MMP9 ¼ matrix metallopeptidase 9; POP ¼ pelvic organ prolapse; Q-PCR ¼ quantitative real-time polymerase chain reaction;
TIMP2 ¼ tissue inhibitor of metalloproteinase 2; UL ¼ uterosacral ligament.
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process and increase the immature collagen III following the tissue
stress. These results support our hypothesis that BMI may be
related to POP in premenopausal women which causes pelvic ﬂoor
stress or injury and may induce a compensation repairing process
with the changes in the elements of ECM and mtDNA copy number
through an energy supplying molecular process of tissue healing
remodeling.
The balance between the synthesis and degradation of collagen
is important for maintaining tissue integrity and tensile strength
during continuous tissue remodeling [7]. Degradation depends
upon the combined activity of MMPs and their regulation of release
[7]. Jackson et al [19] pointed to an alteration in MMPs activity in
the connective tissue of womenwith POP. The mechanical strength
of pelvic supportive structures such as UL may also depend on the
ability of the surrounding cells to degrade the ECM components
through the expression of MMPs [21,23,24]. MMP2 degrades
collagen IV, which is a major component of the basement mem-
brane [24,25]. It is tempting to speculate that elevated MMP2
expression leads to enhanced matrix dissolution and reduced
connective tissue strength, which in turn may facilitate the pro-
gression of POP [23]. In the present study, a signiﬁcantly elevated
MMP2 was found in the POP group (Table 2, p ¼ 0.047 *), which is
consistent with Gabriel's study, suggesting a strong association of
MMP2 with POP in premenopausal women.
An increase in the expression of both collagen III and MMP9
expression is typical of tissue that is remodeling after injury or
accommodating to a progressively increasing mechanical load [26].
However, there was no signiﬁcant difference in MMP9 gene ex-
pressions between the POP and nonPOP groups in this study
(Table 2, p ¼ 0.335). This may be due to the small number of par-
ticipants and relatively young age of our study group.
Recently, some advanced studies have revealed that the
expression ofMMP1, 9 appears to increase in tissues of womenwith
POP [27], whereas an increase in MMP2 mRNA and a decrease in
the tissue inhibitor of metalloproteinase 2 mRNA expression in UL
are related to uterine prolapse in women without urinary inconti-
nence [28]. Table 3 provides summarized prior data following the
analysis of MMPs and their inhibitors in biopsy specimens from
vaginal or supportive tissue in women with or without POP. Many
people wonder whether POP causes tissue changes or tissue
changes cause POP. Although it is still hard to determine whether
the changes in premenopausal women with POP reﬂect the cause
or the effect of prolapse, the results of this study are in accordance
with the concept of the dynamic process of tissue remodeling after
pelvic injury or stress. POP appears to be related to the abnormal
repair of injured tissue after the stress of delivery, obesity, andchronic straining. UL in premenopausal women with POP or high
BMI, characterized by a higher mtDNA copy number and COL3a1
expression, may reﬂect the tissue remodeling process, which leads
to increased tissue laxity. The elevated MMP2 expression causes
enhanced matrix dissolution and reduced connective tissue
strength, which in turn may facilitate the progression of POP.
The study results indicated in the premenopausal state, higher
BMI may be a stronger associate factor than vaginal birth for the
development of POP. The higher mtDNA copy number, COL3a1, and
MMP2 gene expressions are highly associated with POP in the
uterosacral ligaments of premenopausal women.
This study has some limitations: (1) we focused on the effect of
BMI for POP in premenopausal women, so the effect of BMI and
other factors cannot be determined in postmenopausal women; (2)
in addition to the ﬁndings of this study, we believe there are many
other factors and molecular elements that may be associated with
and contribute to POP development and progression. The ﬁndings
may highlight a possible pathophysiologic mechanism of POP, and a
further, wider study may provide a clearer understanding and
prevent the development of POP; and (3) the BMI of women with
POP was signiﬁcantly higher than that of those without POP in the
study, which may be a confounder when comparing the two
groups, but may more clearly indicate the strong relation between
POP and BMI.
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